News - Page 2 of 2 - Lille Eurasante

Home » News » Page 2

Interview : Suman Mitra, researcher at INSERM, CANTHER laboratory and ONCOLille

Biotechnologist and an immunologist, Suman Mitra joined the University of Lille in 2019 and became an Inserm researcher in 2021. His research focuses on understanding and exploiting the activity of…

#european project

Discover the final leaflet of the SMART AGR’HAUTS-DE-FRANCE project

The European project SMART AGR’HAUTS-DE-FRANCE, which aims to support regional agri-food companies in their digital transition, is coming to an end! To conclude this beautiful project, we invite you to…

The european project SMART AGR’Hauts-de-France produces a mapping of the digital technology providers and experts in the region

Supported by the Call for Proposals “Service” of the European Smart Agri Hubs program, the main goal of Smart Agr’Hauts-de-France is to develop new services to raise awareness and support…

4P-PHARMA JOINS FORCES WITH QINGDAO MARINE BIOMEDICAL RESEARCH INSTITUTE FOR TRANSLATION RESEARCH IN CHINA AND EUROPE

4P-Pharma and Qingdao Marine Biomedical Research Institute (QMBRI) have decided to combine their expertise to jointly develop their first-in-class drug candidates in China and Europe through the signature of a Memorandum of Understanding…

ImaBiotech Expands Bioanalytical Pharmaceutical Services in North America with Pyxant Labs Colorado and Salt Lake City Sites

ImaBiotech Group today announced the creation of an innovative global bioanalytical CRO with Pyxant Labs Inc Colorado Springs and Salt Lake City sites The integration of the expertise, innovation and…

Tada Medical and partners raised €5.8m grants through three successful applications at European programmes

EIC Accelerator, EIC Fast Track to Innovation and Eurostars-2 are known as challenging European programmes for innovative companies. Tada Medical, a MedTech company based in Sweden and accelerated in Lille…

Can-Fite Enters Projected $3 Billion Veterinary Osteoarthritis Market: Signs Agreement with Vetbiolix for Development of Piclidenoson for Pets

Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, today announced it has signed…